Decision makers at hospitals expect increasingly sophisticated concepts for representing refinancing of pharmaceutical products and medical devices as one of the manufacturer’s obligations to deliver in the framework of the G-DRG system. This also applies increasingly to the health sectors in Switzerland and Austria. Companies possessing this competence secure a decisive competitive advantage for themselves.

Are you responsible for successful marketing of a medical device or pharmaceutical preparation? Do you see potential in the refinancing of your product? Would you like more clarity about the complex relationships in the German invoicing system, and do you seek expertise in the strategic positioning of your product?

In a results-oriented manner, we guide you through the reimbursement maze. Based on our many years of experience with the G-DRG system, we support you competently in all aspects of health economics concerning your product.